BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21917858)

  • 1. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
    Xu Q; Liu LZ; Qian X; Chen Q; Jiang Y; Li D; Lai L; Jiang BH
    Nucleic Acids Res; 2012 Jan; 40(2):761-74. PubMed ID: 21917858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.
    Shi ZM; Wang J; Yan Z; You YP; Li CY; Qian X; Yin Y; Zhao P; Wang YY; Wang XF; Li MN; Liu LZ; Liu N; Jiang BH
    PLoS One; 2012; 7(3):e32709. PubMed ID: 22442669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression.
    Bian CX; Shi Z; Meng Q; Jiang Y; Liu LZ; Jiang BH
    Biochem Biophys Res Commun; 2010 Jul; 398(3):395-9. PubMed ID: 20599538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
    Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.
    Liu LZ; Hu XW; Xia C; He J; Zhou Q; Shi X; Fang J; Jiang BH
    Free Radic Biol Med; 2006 Nov; 41(10):1521-33. PubMed ID: 17045920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.
    Liu LZ; Zheng JZ; Wang XR; Jiang BH
    Cancer Res; 2008 Oct; 68(19):8183-8. PubMed ID: 18829578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS; Zheng JZ; Reed E; Jiang BH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
    Wu H; Xiao Z; Wang K; Liu W; Hao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A.
    Wei L; Sun C; Zhang Y; Han N; Sun S
    Gene Ther; 2022 Feb; 29(1-2):28-40. PubMed ID: 32533103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
    Yan S; Wang H; Chen X; Liang C; Shang W; Wang L; Li J; Xu D
    Cancer Lett; 2020 Sep; 488():18-26. PubMed ID: 32473243
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tsai HL; Tsai YC; Chen YC; Huang CW; Chen PJ; Li CC; Su WC; Chang TK; Yeh YS; Yin TC; Wang JY
    Aging (Albany NY); 2022 Aug; 14(16):6668-6688. PubMed ID: 35997665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis.
    He J; Jing Y; Li W; Qian X; Xu Q; Li FS; Liu LZ; Jiang BH; Jiang Y
    PLoS One; 2013; 8(2):e56647. PubMed ID: 23437196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
    Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
    Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis.
    Cha ST; Chen PS; Johansson G; Chu CY; Wang MY; Jeng YM; Yu SL; Chen JS; Chang KJ; Jee SH; Tan CT; Lin MT; Kuo ML
    Cancer Res; 2010 Apr; 70(7):2675-85. PubMed ID: 20233879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
    Skinner HD; Zheng JZ; Fang J; Agani F; Jiang BH
    J Biol Chem; 2004 Oct; 279(44):45643-51. PubMed ID: 15337760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.
    Seok JK; Lee SH; Kim MJ; Lee YM
    Nucleic Acids Res; 2014 Jul; 42(12):8062-72. PubMed ID: 24914051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of miR-18a in gastric cancer angiogenesis.
    Zheng Y; Li S; Ding Y; Wang Q; Luo H; Shi Q; Hao Z; Xiao G; Tong S
    Hepatogastroenterology; 2013 Oct; 60(127):1809-13. PubMed ID: 24624454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.